癌症临床试验中的生活质量：研究人员、患者和政策制定者。
Quality of life in cancer clinical trials: researchers, patients and policy makers.
机构信息
Expert Reviews Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK.
出版信息
Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):661-5. doi: 10.1586/erp.11.84.
The second symposium of the European Organisation for Research and Treatment of Cancer took place in September 2011 at the European Parliament in Brussels (Belgium). The aim of the symposium was to discuss a wide range of topics in health-related quality of life, symptom research and cancer clinical trials, including their design, implementation and analysis. Faculty and attendees included key opinion leaders in their fields, among them many Editorial Board members of Expert Review of Pharmacoeconomics & Outcomes Research, along with EU legislators and European patient groups, allowing increased collaboration between these different stakeholders in quality-of-life research in cancer clinical trials.
2011 年 9 月，欧洲癌症研究与治疗组织（EORTC）的第二次研讨会在布鲁塞尔（比利时）的欧洲议会举行。本次研讨会的目的是讨论与健康相关的生活质量、症状研究和癌症临床试验的广泛主题，包括它们的设计、实施和分析。与会人员包括该领域的主要意见领袖，其中许多人是《药效经济学与结果研究杂志》（Expert Review of Pharmacoeconomics & Outcomes Research）的编委会成员，此外还有欧盟立法者和欧洲患者团体，这使得癌症临床试验中的生活质量研究不同利益相关者之间的合作得到加强。
Zotero 插件